Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Ping An Healthcare and Technology Company ( (HK:1833) ) has provided an update.
Ping An Healthcare and Technology Company shareholders approved all resolutions at the 23 April 2026 annual general meeting in Shanghai, with approximately 59.7% of issued shares represented in person or by proxy. The meeting endorsed the 2025 audited financial statements, re-elected five directors, confirmed board authority on director remuneration, and renewed the mandate for Ernst & Young as auditor for 2026.
Investors also granted the board general mandates to issue up to 20% additional shares, repurchase up to 10% of outstanding shares and extend the issuance mandate by the amount of shares bought back. The strong voting support across all items reinforces the company’s financial reporting framework, board composition and capital management flexibility, potentially strengthening its position in the competitive digital healthcare sector.
The most recent analyst rating on (HK:1833) stock is a Hold with a HK$12.40 price target. To see the full list of analyst forecasts on Ping An Healthcare and Technology Company stock, see the HK:1833 Stock Forecast page.
More about Ping An Healthcare and Technology Company
Ping An Healthcare and Technology Company Limited is a Hong Kong-listed provider of digital healthcare services and technology solutions, operating within the broader healthcare and technology sectors. The company focuses on leveraging online platforms and data-driven tools to deliver medical consultation, health management and related services to users in mainland China and beyond.
Average Trading Volume: 9,861,982
Technical Sentiment Signal: Hold
Current Market Cap: HK$26.48B
Learn more about 1833 stock on TipRanks’ Stock Analysis page.